Number of Lawsuits Increases Fivefold to Over 2,100 Since May- FDA Approves Brain Tumour WarningGlobal pharmaceutical company Pfizer Inc. (NYSE: PFE), manufacturer of contraceptive injection ...
Recent studies how found evidence that Depo-Provera massively increases the risk of developing brain tumors even after women ...
The MarketWatch News Department was not involved in the creation of this content. The number of lawsuits filed has tripled to over 1300 since May New US peer-reviewed study adds to body of research ...
Pfizer Inc. (NYSE: PFE) faces mounting legal challenges over claims that its contraceptive injection Depo-Provera (DMPA) is linked to brain tumors, with a key court hearing set for late September that ...
A study published on 29 June 2025 in international peer reviewed medical journal Expert Opinion on Drug Safety by Frey et al. has found that use of Pfizer’s Depo-Provera (DMPA) for more than one year ...
Risk factors for repeat pregnancy terminations include teenage pregnancy, social deprivation, two or more previous live births or miscarriages at the time of the initial termination, and the use of ...
The MarketWatch News Department was not involved in the creation of this content. -- Global pharmaceutical company Pfizer Inc. is facing a multidistrict litigation (MDL No.3140) in the USA, currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback